Close Menu

NEW YORK (GenomeWeb) — In the hope of preventing gonorrhea from becoming the next antimicrobial-resistant "superbug," researchers at the University of California, Los Angeles have been awarded a two-year, $270,000 National Institutes of Health grant to validate a real-time PCR assay for drug resistance and incorporate it into routine gonorrhea testing.

Jeffery Klausner, a professor of medicine and public health at UCLA and a well-known public health researcher in the field of sexually transmitted infections, is spearheading the efforts based on a PCR assay he previously developed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.